Expression, purification and characterization of murine Dkk1 protein

被引:5
|
作者
Fleury, Damien [1 ]
Gillard, Corinne [1 ]
Lebhar, Helene [1 ]
Vayssiere, Beatrice [1 ]
Touitou, Robert [1 ]
Rawadi, Georges [1 ]
Mollat, Patrick [1 ]
机构
[1] Galapagos SASU, Prot Sci, F-93230 Romainville, Seine Saint Den, France
关键词
Dkk1; protein; highly expressing cell line; purification; characterization; Dickkopf; glycosylation; Wnt pathway;
D O I
10.1016/j.pep.2008.03.023
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Dickkopf-1 (Dkk1) protein is a secreted inhibitor of canonical Writ signaling and modulates that pathway during embryonic development. It is also implicated in several diseases and hence Dkk1 is a potential target for therapeutic intervention. In the present study 6His-tagged Dkk1 expression and secretion was assessed in five mammalian cell types. Only FreeStyle 293-F cells showed significant Dkk1 protein expression in culture medium. High and stable expression of the Dkk1 protein was obtained from a selected stable FreeStyle 293-F clone 3178, that grows in suspension in serum-free medium. The 3178 clone showed a high Dkk1 production level (10 mg/L) for up to 2 months of culture. A one step purification procedure resulting in large amounts of highly pure and active Dkk1 protein was developed. Purified Dkk1 binds its receptors LRP5 and LRP6, and is able to dose dependently inhibit canonical Writ signaling. Recombinant Dkk1 is glycosylated, but this modification is not essential for its biological activity. In summary, an abundant source of pure and functionally active Dkk1 protein is developed that will support the identification of inhibitors such as neutralizing antibodies that could find therapeutic use. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:74 / 81
页数:8
相关论文
共 50 条
  • [21] DKK1 as a chemoresistant protein modulates oxaliplatin responses in colorectal cancer
    Hsieh, Chi-Che
    Li, Ting-Wei
    Li, Chun-Chun
    Chen, Shang-Hung
    Wei, You-Lin
    Chiang, Nai-Jung
    Shen, Che-Hung
    ONCOGENESIS, 2024, 13 (01):
  • [22] Sclerostin and DKK1 in Primary Hyperparathyroidism
    Ombretta Viapiana
    Elena Fracassi
    Sonila Troplini
    Luca Idolazzi
    Maurizio Rossini
    Silvano Adami
    Davide Gatti
    Calcified Tissue International, 2013, 92 : 324 - 329
  • [23] Decreased expression of Dkk1 and Dkk3 in human clear cell renal cell carcinoma
    Guo, Chang-Cheng
    Zhang, Xiao-Long
    Yang, Bin
    Geng, Jiang
    Peng, Bo
    Zheng, Jun-Hua
    MOLECULAR MEDICINE REPORTS, 2014, 9 (06) : 2367 - 2373
  • [24] Drug Discovery of DKK1 Inhibitors
    Jiang, Hewen
    Zhang, Zongkang
    Yu, Yuanyuan
    Chu, Hang Yin
    Yu, Sifan
    Yao, Shanshan
    Zhang, Ge
    Zhang, Bao-Ting
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [25] Sclerostin and DKK1 in Primary Hyperparathyroidism
    Viapiana, Ombretta
    Fracassi, Elena
    Troplini, Sonila
    Idolazzi, Luca
    Rossini, Maurizio
    Adami, Silvano
    Gatti, Davide
    CALCIFIED TISSUE INTERNATIONAL, 2013, 92 (04) : 324 - 329
  • [26] Comparative genomics on Dkk1 orthologs
    Katoh, Y
    Katoh, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 27 (01) : 275 - 279
  • [27] Converging on DKK1 to drive metastasis
    不详
    SCIENCE, 2020, 370 (6518)
  • [28] The Role of DKK1 in the development of vitiligo
    Kim, J. Y.
    Shin, J. Y.
    Kim, M. R.
    Oh, S. H.
    PIGMENT CELL & MELANOMA RESEARCH, 2011, 24 (04) : 787 - 787
  • [29] Expression and Role of Dickkopf-1 (Dkk1) in Tumors: From the Cells to the Patients
    Zhu, Guohua
    Song, Jukun
    Chen, Weimin
    Yuan, Dongbo
    Wang, Wei
    Chen, Xiaoyue
    Liu, Hen
    Su, Hao
    Zhu, Jianguo
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 659 - 675
  • [30] Distinct roles of DKK1 and DKK2 in tumor angiogenesis
    Hongryeol Park
    Hyei Yoon Jung
    Hyun-Jung Choi
    Dong Young Kim
    Ji-Young Yoo
    Chae-Ok Yun
    Jeong-Ki Min
    Young-Myoung Kim
    Young-Guen Kwon
    Angiogenesis, 2014, 17 : 221 - 234